ASX:4DXHealthcare Services
Assessing 4DMedical’s Valuation After Julian Sutton’s CFO Appointment And CT:VQ Commercial Progress
Why Julian Sutton’s promotion matters for 4DMedical shareholders
The recent 18% jump in 4DMedical (ASX:4DX) followed the appointment of long-time board member and early investor Julian Sutton as Chief Financial Officer and Executive Director on January 2, 2026.
This move comes as the company shifts focus toward commercial growth, with its CT:VQ lung imaging software already FDA cleared, deployed at leading U.S. academic medical centres, and supported by a global distribution agreement with...